What is Adaptive Biotechnologies's AOCI?

Adaptive Biotechnologies (ADPT) reported AOCI of -$28K in Q1 2026.

How has Adaptive Biotechnologies's AOCI changed year-over-year?

Adaptive Biotechnologies's AOCI decreased by 120.9% year-over-year, from $134K to -$28K.

What is the long-term trend for Adaptive Biotechnologies's AOCI?

Over 5 years (2020 to 2025), Adaptive Biotechnologies's AOCI has grown at a -22.3% compound annual growth rate (CAGR), from $893K to $253K.

Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.

Adaptive Biotechnologies ADPT AOCI

AOCI at other companies

Guardant HealthGH

-$5.15M-10.6%

Natera, Inc.NTRA

-$202K-2.5%

Monte Rosa Therapeutics, Inc.GLUE

-$4.75M-42.6%

GeneDx HoldingsWGS

$683K-24.5%

VeracyteVCYT

-$8.22M+71.3%

Nurix Therapeutics, Inc.NRIX

$56K-75.2%

Other financials

Income statement

See full

Revenue$70.9M+35.1%

Gross profit$52.2M+47.1%

Operating income-$19.2M+35.1%

Net income-$20.0M+32.9%

EPS (diluted)-$0.13+35.0%

Balance sheet

See full

Cash & equivalents$77.6M+53.2%

Total debt$208.2M-5.6%

Total equity$216.3M+13.6%

Total assets$505.9M-1.0%

Cash flow

See full

Operating cash flow-$9.5M+66.5%

CapEx$796.0K-36.8%

Free cash flow-$10.3M+65.3%

Valuation

See full

Market cap$2.76B+93.6%

Enterprise value$2.89B+78.0%

P/S9.3×+1.8×

Profitability

See full

Gross margin75.3%+12.7pp

Operating margin-15.8%-7.0pp

Net margin-16.8%-7.3pp

FCF margin-10.5%-4.6pp

Returns & leverage

See full

Return on equity-24.4%-9.2pp

Debt / equity1×-0.2×

Current ratio3.4×+0.4×

Where this comes from

Reported directly by Adaptive Biotechnologies in its filing.

Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.

The official record: Adaptive Biotechnologies’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Adaptive Biotechnologies's aoci.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Adaptive Biotechnologies's AOCI?: Adaptive Biotechnologies (ADPT) reported AOCI of -$28K in Q1 2026.
How has Adaptive Biotechnologies's AOCI changed year-over-year?: Adaptive Biotechnologies's AOCI decreased by 120.9% year-over-year, from $134K to -$28K.
What is the long-term trend for Adaptive Biotechnologies's AOCI?: Over 5 years (2020 to 2025), Adaptive Biotechnologies's AOCI has grown at a -22.3% compound annual growth rate (CAGR), from $893K to $253K.
What does AOCI mean?: Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.